https://www.selleckchem.com/products/jib-04.html testing day and repeated measurements within calf when appropriate. Twenty-four Holstein and crossbred calves (PR n = 12, 6 pairs; INDV n = 12) were enrolled from November 2 to December 23, 2018. The PR calves were 7.1 kg heavier at weaning and gained 0.15 kg/d more during the preweaning period as compared with INDV calves. In the 24 h after movement to the postweaning pen, PR calves lay down for longer periods of time (14.3 vs. 11.0 ± 0.4 h/d), and PR calves urinated more during novel object testing at 5 wk of age. Our study demonstrated benefits, such as better growth and increased lying time, of pair housing calves during the preweaning period.The objective of this study was to quantify the efficacy of a second intrauterine cephapirin treatment administered 14 d after the initial one on subsequent reproductive performance of postpartum dairy cows affected by purulent vaginal discharge (PVD) or endometritis (ENDO). In total, 4,140 Holstein cows from 30 commercial herds were enrolled in a randomized clinical trial. At 36 (±7) d in milk, cows were examined using the Metricheck device to diagnose PVD. An endometrial cytology sample was also collected from each cow to perform a leukocyte esterase test for diagnosing ENDO. Diagnosis of PVD and ENDO was done cow-side. Cows diagnosed with PVD or ENDO were assigned to receive 1 of 2 treatments (1) a single intrauterine cephapirin infusion (500 mg of cephapirin benzathin; Metricure, Merck Animal Health, Kirkland, QC, Canada) at the time of initial examination or (2) a single intrauterine infusion at the time of initial examination and a second one 14 d later. Subsequent reproductive and culling events were collected until 200 d in milk. Statistical analyses were performed using univariable and multivariable mixed logistic regression models. In cows affected by PVD, a second intrauterine cephapirin infusion increased the pregnancy risk at first insemination in comparison with